Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Why the weirdest sea level changes on Earth are happening off the coast of Japan - 27 Espresso Machines for Home Baristas
- 3Journey Travel Objections for Your Next Experience
- 4Arctic sea ice hits lowest winter level as unprecedented heat hits smashes records all over Earth
- 55 Food varieties to Remember for Your Eating regimen for Ideal Wellbeing
- San Francisco sues 10 companies that make ultraprocessed food
- Support Your Investment funds with These Individual accounting Thoughts
- Jeff Bezos’ Blue Origin launches landmark Mars mission in New Glenn rocket’s first big test
- ADHD drugs work, but not the way experts thought
- Virtual reality opens doors for older people to build closer connections in real life
- Step by step instructions to Explore the Close to home Consequence of Cellular breakdown in the lungs
- Everyday Seasonal Positions That Compensate Fairly in the US
- Ukrainian troops showed 'greater tactical imagination' than Western trainers, British officer says, pointing to their ambush tactics
- EU agrees on agriculture safeguards as fronts harden in Mercosur deal
